amsacrine has been researched along with Cytomegalic Inclusion Disease in 1 studies
Amsacrine: An aminoacridine derivative that intercalates into DNA and is used as an antineoplastic agent.
amsacrine : A sulfonamide that is N-phenylmethanesulfonamide substituted by a methoxy group at position 3 and an acridin-9-ylamino group at position 4. It exhibits antineoplastic activity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, ES | 1 |
| Benson, JD | 1 |
| Huong, SM | 1 |
| Wilson, B | 1 |
| van der Horst, C | 1 |
1 other study available for amsacrine and Cytomegalic Inclusion Disease
| Article | Year |
|---|---|
Irreversible inhibition of human cytomegalovirus replication by topoisomerase II inhibitor, etoposide: a new strategy for the treatment of human cytomegalovirus infection.
Topics: Amsacrine; Cell Division; Cell Line; Cell Survival; Cytomegalovirus; Cytomegalovirus Infections; DNA | 1992 |